EDTUTC-4 New YorkLog in Sign up

SPRY
ARS Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 4:00:01 PM EDT

4.07USD-1.214%(-0.05)1,828,672

Pre-marketOct 2, 2026 9:25:30 AM EDT

4.20USD+1.942%(+0.08)

After-hoursOct 2, 2026 4:30:30 PM EDT

4.08USD+0.246%(+0.01)

Loading…

Loading…

404.75M

Healthcare

Biotechnology

HQ

San Diego, CA, USA

27

Previous Close

$4.12

Beta

1.54

52-Week High

$13.15 2026-01-12

52-Week Low

$3.99 2026-10-02

SMA 50

$5.26

SMA 200

$8.11

Avg. Vol 10D

1.32M

Avg. Vol 30D

1.47M

Avg. Vol 90D

1.86M

Relative Vol

1.25

99.45M

64.50M

64.86%

23,073,209

Short Interest %

35.77%

15.51

On/Off Exchange

62%/38%

69.39%

Short Vol % (off-exch)

57.51%

1.8700%

5,100,000

1,669

20,252

99,740

Nov 9, 2026 (35d)

Oct 5, 2026

03:28 AM EDTARS Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SPRY ·

PR Newswire

03:22 AM EDTSPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law ·

PR Newswire

Oct 4, 2026

02:16 PM EDTARS PHARMACEUTICALS DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY ·

Newsfile

08:53 AM EDTSPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 ·

Newsfile

Oct 3, 2026

08:41 AM EDTSPRY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 ·

Newsfile

SPRY Profile

silverback therapeutics is a biotechnology company that was founded in 2016. the company is based in seattle, wa and is funded by orbimed.

SPRY Performance

Period	Price	Date	Change	Beta
1W	4.13	2026-09-28	-1.45%	-3.962
1M	5.62	2026-09-04	-27.58%	1.969
3M	8.33	2026-07-06	-51.14%	1.109
6M	8.39	2026-04-06	-51.49%	1.055
1Y	10.31	2025-10-03	-60.52%	1.542
2Y	14.19	2024-10-04	-71.32%	—
5Y	6.00	2022-11-10	-32.17%	0.820

SPRY Stock Summary

ARS Pharmaceuticals, Inc. Common Stock (NASDAQ:SPRY) stock price today is $4.07, and today's volume is 1,828,672. SPRY is down 1.214% today. The 30 day average volume is 1.47M. SPRY market cap is $404.75M with 99.45M shares outstanding.